John Kenneth Rose
Affiliations: | 1978-1986 | Salk Institute for Biological Studies, La Jolla, CA, United States | |
| 1986- | Pathology and Cell Biology | Yale University School of Medicine, New Haven, CT |
Area:
Molecular VirologyWebsite:
http://people.yale.edu/search/john_rose.profileGoogle:
"John Kenneth Rose"Bio:
http://medicine.yale.edu/lab/rose/research/
https://books.google.com/books?id=ucdFAAAAIAAJ
Mean distance: (not calculated yet)
Cross-listing: Cell Biology Tree
Parents
Sign in to add mentor| Charles Yanofsky | grad student | 1973 | Stanford | |
| (Regulation of the tryptophan operon of Escherichia coli: in vivo and in vitro studies.) | ||||
| David Baltimore | post-doc | MIT | ||
| Harvey F. Lodish | post-doc | MIT | ||
Children
Sign in to add trainee| Melissa M. Rolls | research assistant | 1992-1996 | Yale (Cell Biology Tree) |
| Jun-Lin Guan | grad student | 1987 | UCSD |
| Miriam I. Quinones-Kochs | grad student | 2001 | Yale |
| Karl E. Haglund | grad student | 2002 | Yale |
| Lisa D. Schlehuber | grad student | 2004 | Yale |
| Jean M. Publicover | grad student | 2006 | Yale |
| Sagar U. Kapadia | grad student | 2008 | Yale |
| Ian D. Simon | grad student | 2008 | Yale |
| Sara E. Crager | grad student | 2011 | Yale |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chiale C, Yarovinsky TO, Mason SW, et al. (2020) Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B. Vaccines. 8 |
| Lo MK, Spengler JR, Krumpe LRH, et al. (2020) Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge. The Journal of Infectious Diseases |
| Yarovinsky TO, Mason SW, Menon M, et al. (2019) Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B. Iscience. 21: 391-402 |
| Chiale C, Moshkani S, Rose JK, et al. (2019) Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV core antigen induces CD8 T cell responses in naïve and persistently infected mice and protects from challenge. Antiviral Research |
| Moshkani S, Chiale C, Lang SM, et al. (2018) A highly attenuated vesicular stomatitis virus-based vaccine platform controls HBV replication in mouse models of hepatitis B. Journal of Virology |
| Chattopadhyay A, Aguilar PV, Bopp NE, et al. (2018) A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections. Vaccine |
| Baquero E, Albertini AA, Raux H, et al. (2017) Structural intermediates in the fusion-associated transition of vesiculovirus glycoprotein. The Embo Journal. 36: 679-692 |
| van den Pol AN, Mao G, Chattopadhyay A, et al. (2017) Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain. Journal of Virology. 91 |
| Okuma K, Fukagawa K, Kohma T, et al. (2017) A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection. Microbes and Infection. 19: 277-287 |
| Clarke DK, Hendry RM, Singh V, et al. (2016) Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 34: 6597-6609 |